Why the study?
Does ouabain prevent ischemia-reperfusion injury in Langendorff-perfused rat hearts?
Does ouabain prevent ischemia-reperfusion injury in Langendorff-perfused rat hearts?
Ouabain provides cardioprotection against ischemia-reperfusion injury in rat hearts via a pathway involving src kinase, mitoKATP, and ROS, which diverges from its inotropic signaling pathway.
No takes yet. Share an insight, caveat, or question.
No immediate clinical role for ouabain; leaves open whether src kinase-mitoKATP-ROS targeting yields human cardioprotection.
Pasdois et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: